S

Stryker

Manufactures orthopedic and surgical medical devices

Finance Analyst - UK and Ireland

Full-Time
£38.6k - £64.3k/yr+ Bonus + Commission
Mid
Newbury, UK
HybridTwo days per week in the office.
AccountingFinancial Accounting

About the job

Requirements
  • Be a fully qualified accountant (ACCA, CIMA, ICAEW or equivalent) with strong technical accounting knowledge.
  • Have demonstrable experience in a complex, fast-paced finance function or accounting practice, with the credibility to operate independently.
  • Have strong experience of month-end close, balance sheet control, statutory reporting, audit and tax compliance.
  • Have proven relevant industry experience in a large organisation.
  • Be able to analyse complex financial information, identify root causes, form independent conclusions and translate findings into clear actions.
  • Have experience overseeing work delivered by others, including setting expectations, reviewing quality and driving timely resolution of issues.
  • Have advanced Excel skills and confidence working with large data sets.
  • Demonstrate proactive ownership and accountability by taking end-to-end responsibility for deliverables, managing dependencies and driving actions through to completion without repeated prompting.
  • Produce consistently reliable, well-supported work; apply self-review, understand the wider financial impact of outputs and identify issues before they reach stakeholders.
  • Interrogate underlying data, identify root causes and reach sound conclusions independently rather than relying on others to provide answers.
  • Demonstrate curiosity and professional scepticism, challenge unusual outcomes and established ways of working, and suggest practical improvements.
  • Build a strong one-team relationship with the Polish Finance Centre while maintaining clear accountability for quality, deadlines and resolution of issues.
  • Prioritise effectively across multiple workstreams, work calmly under pressure and consistently meet demanding month-end, statutory and corporate deadlines.
  • Select effective approaches to solving issues based on available information and business objectives.
  • Build understanding quickly, retain and apply feedback, and become increasingly effective with limited supervision.
  • Bring energy, resilience and a strong personal commitment to raising standards and adding value across the organisation.
Responsibilities
  • Own the integrity, accuracy and completeness of financial results, ensuring all material balances and transactions are understood, appropriately accounted for and supported by a clear audit trail.
  • Lead key elements of the month-end and quarter-end close, proactively managing the timetable, identifying risks early and ensuring issues are resolved without compromising quality or deadlines.
  • Review the profit and loss account, balance sheet and underlying data; independently investigate variances, identify root causes and present clear conclusions and recommended actions.
  • Assist with the review and quality of balance sheet reconciliations, challenge aged, unusual or unsupported items, and drive corrective actions to completion.
  • Support the local review and coordination of annual statutory financial statements and external audit deliverables, working with the Polish Finance Centre, auditors and internal stakeholders.
  • Oversee accounting for assigned legal entities and high-risk areas, including revenue, accruals and tax.
  • Ensure intercompany cross-charges are accurate, appropriately supported and completed on time, and lead resolution of related issues.
  • Assess control performance and supporting evidence, independently identify deficiencies and root causes, and determine practical remediation actions.
  • Maintain process narratives, risk and control matrices and related documentation that accurately reflect current processes and responsibilities.
  • Partner with process owners and the Polish Finance Centre to strengthen control execution, hold stakeholders accountable for agreed actions and ensure remediation is delivered on time.
  • Challenge existing processes and lead continuous improvement initiatives that improve accuracy, control, efficiency and scalability.
  • Lead work in the UK Senior Accounting Officer compliance programme by assessing tax controls and driving timely actions with process owners.
  • Maintain tax control frameworks, risk matrices and process narratives, ensuring risks are understood and controls remain effective.
  • Coordinate the timely and accurate delivery of corporation tax, PSA, ERS and other local compliance requirements with internal teams and external advisers.
  • Maintain strong relationships with internal tax stakeholders and external advisers.
  • Act as the key Local Finance partner to the Polish Finance Centre, set expectations, critically review outputs and hold teams accountable for quality and delivery.
  • Lead or contribute to local and regional finance projects, applying financial control, technical accounting and practical implementation expertise.
  • Manage competing priorities and critical corporate and divisional deadlines with minimal supervision, escalate risks early and propose solutions.
  • Build trusted relationships across Finance and the wider business.
  • Promote a culture of ownership, continuous improvement and high-quality work across the wider finance team.
Desired Qualifications
  • Power BI capability is strongly preferred.

About the company

Stryker makes medical devices for hospitals, surgical centers and emergency responders, spanning joint implants, surgical instruments and patient transport equipment. Its Mako platform assists surgeons with joint replacement, while its neurotechnology products support brain and spine procedures and stroke treatment. Clinicians use its equipment during surgery and emergency care, and the company earns money by selling implants, disposable products and capital equipment through direct sales teams and distributors. The business also supplies training and technical support for healthcare providers using its devices. Stryker was founded in 1941 and is headquartered in Portage, Michigan.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand supports growth: July 2026 Stryker results show organic sales rose 9%, with reported sales reaching $6.6 billion.
  • Service extends equipment sales: Stryker's ProCare contracts bundle preventive maintenance, repairs and original manufacturer parts.
  • Relocation is available for Worcester technicians: Stryker's live transport service opening also lists 12 paid holidays.

What critics are saying

  • Operational failures reach customers: March 2026 cyberattack disrupted Stryker's ordering, manufacturing and shipping.
  • Older implants retain legal exposure: Stryker's recall estimates include Rejuvenate, LFIT V40 and legacy Wright hip products.
  • Field service demands travel: Stryker's northern Minnesota opening lists 80% travel plus evening or weekend call.

What makes Stryker unique

  • Mako combines imaging and physical guidance: Stryker uses CT-based planning and haptic boundaries during hip replacement.
  • Discarded devices return to service: Stryker's Sustainability Solutions reprocesses medical equipment for hospitals across the U.S. and Canada.
  • Transport extends its technology outside hospitals: Stryker's Power-LOAD supports stretchers while loading and unloading ambulances.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical & prescription plans
  • Supplemental health benefits
  • Flexible Spending accounts
  • Employee Assistance Program
  • Short-term & long-term disability
  • Tuition reimbursement
  • 401(k) plan
  • Employee Stock Purchase Plan

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 21st, 2026
P&G and Stryker: two dividend stocks to hold for decades

Procter & Gamble and Stryker are two dividend stocks suited to long-term holders, according to the article. Both sell products people need in any economy. P&G has raised its dividend for 70 consecutive years. In fiscal 2026, it posted net sales of about $87 billion, up 3%, and net earnings of $16.1 billion. It returned more than $15 billion to shareholders, including $10.2 billion in dividends. Organic sales and core earnings per share each grew just 1%. Stryker has raised its dividend for more than three decades. Second-quarter 2026 revenue rose 9.4% to $6.6 billion, and adjusted earnings per share climbed 17.9% to $3.69. Demand should gain from an ageing US population, though recalls, acquisition costs, and hospital spending pressures remain risks.

Yahoo Finance
Oct 14th, 2026
Stryker wins FDA clearance for Sonopet 3 ultrasonic bone and tissue removal platform

Stryker has received US Food and Drug Administration (FDA) 510(k) clearance for Sonopet 3, the latest version of its ultrasonic bone and soft tissue removal platform. The company announced the news on October 14, 2026. Stryker developed the platform with input from hundreds of surgeons. It offers more power, precision and versatility, along with two technologies: RISE, which connects the surgical workflow, and Pulse Control, which helps regulate the resection of hard and soft tissues. "They told us they wanted more power, improved ergonomics and enhanced integration," said Mitch Foley, vice president and general manager of Stryker's Neurosurgical business. The first clinical cases are expected to begin in October. A full commercial launch is planned for later this fall.

Yahoo Finance
Oct 12th, 2026
Stryker shares fall 20% in six months despite 9.2% organic growth and $25.84B revenue

Stryker (NYSE:SYK) shares have fallen 20% over the past six months to $277.82, while the S&P 500 gained 12.8%. The medical device maker develops orthopedic, surgical, neurotechnology, and patient care products that reach over 150 million patients a year. Organic revenue, which excludes acquisitions, divestitures, and currency swings, grew an average of 9.2% year-on-year over the past two years. That suggests Stryker can expand without costly acquisitions. Revenue over the past 12 months was $25.84 billion. Its scale gives it leverage with suppliers in a heavily regulated, competitive market. Free cash flow margin rose 6.5 percentage points over five years to 18.2% for the trailing 12 months. After the drop, the stock trades at 17.4× forward earnings.

Seeking Alpha
Oct 12th, 2026
Stryker to invest $400M in CMR Surgical, with option to buy the robotics maker outright

Stryker announced a $400 million (£300 million) preferred equity investment in CMR Surgical on Monday. The money will support innovation and global expansion of CMR's Versius surgical robotics portfolio. The deal also gives Stryker an exclusive option to acquire 100% of CMR Surgical.

PR Newswire
Oct 5th, 2026
Stryker launches Mako 4 SmartRobotics in India after 2.5M procedures globally

Stryker has launched Mako 4 SmartRobotics in India, introducing the fourth generation of its robotic-arm assisted technology for joint replacement procedures. The system combines patient-specific planning, robotic technology, and haptic guidance for total knee, partial knee, and total hip applications. Mako 4 uses 3D CT-based planning with AccuStop haptic technology to support surgeons in planning and executing procedures according to individual patient anatomy. The platform provides real-time intraoperative guidance for greater precision during joint replacement procedures. The global Mako platform has supported more than 2.5 million procedures across 47 countries. Aman Rishi, Stryker's vice president and general manager for India, said the launch aims to raise the standard of care and expand access for joint replacement patients nationwide.